Startup ASEAN

CytoMed Therapeutics Pte Ltd

View Website

Related Keywords

ACTIVE Healthcare & Education Biotechnology

Headquarter Location

ONE COMMONWEALTH 1 COMMONWEALTH LANE #08-22 Singapore 149544

Company Profile Incorporated in 2018, CytoMed Therapeutics Pte Ltd (“CytoMed”), a spin-off from Singapore’s Agency for Science, Technology and Research (A*Star), focuses on translating its two patented technologies into allogeneic donor cell-based immuno-therapies centred on CAR gamma delta (γδ) T cells and induced pluripotent stem cell-derived γδ NK T cells, which could be safer and more accessible to patients. CytoMed was listed among the top 100 CAR T companies in the world.CytoMed is a deep tech biotech company specialising in cell therapy. In particular, CytoMed’s cell therapy solution focuses on “off-the-shelf” donor allogeneic cellular therapeutics products which are not personalised and do not require patient matching for therapeutic use. CytoMed’s raw material is sourced from blood, umbilical cord or adipose tissue of healthy donor and clients.

Overview

Website

https://www.cytomed.sg/

enquiry@cytomed.sg

Founded Date

2018-03-09

Company Size

Company Stage

Industry

Healthcare & Education

Technology

Biotechnology

Client Focus

B2B

Status

ACTIVE

Headquarter Location

ONE COMMONWEALTH 1 COMMONWEALTH LANE #08-22 Singapore 149544